Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Vaccinations

Vaccinations

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Leishmaniasis

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses.

Parasite immunology·2018

Same author

Immunology of human schistosomiasis.

Parasite immunology·2014

Same author

Relative imbalance between T regulatory cells and activated T cells in mice with differential morbidity in chronic Schistosoma mansoni infections.

Parasite immunology·2009

Same author

Early responses associated with chronic pathology in murine schistosomiasis.

Parasite immunology·2007

Same author

A study of the environmental determinants of malaria and schistosomiasis in the Philippines using Remote Sensing and Geographic Information Systems.

Parassitologia·2005

Same author

PD-L2+ dendritic cells and PD-1+ CD4+ T cells in schistosomiasis correlate with morbidity.

Parasite immunology·2005

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Published on: August 16, 2011

Schistosomiasis vaccine:research to development.

N R Bergquist¹, D G Colley

¹Coordinator of Strategic Research at the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), World Health Organization, CH-1211 Geneva 27, Switzerland.

Parasitology Today (Personal Ed.)

|October 17, 2006

Summary

International experts convened to review schistosomiasis vaccine development progress. They aimed to consolidate global efforts and recommend future directions for creating a vital schistosomiasis vaccine.

More Related Videos

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Published on: May 22, 2018

A High-throughput Shigella-specific Bactericidal Assay

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Related Experiment Videos

Last Updated: Jul 19, 2026

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules

Published on: August 16, 2011

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum

Published on: May 22, 2018

A High-throughput Shigella-specific Bactericidal Assay

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Area of Science:

Tropical medicine
Vaccinology
Parasitology

Background:

Schistosomiasis remains a significant global health burden, necessitating effective control strategies.
The development of a schistosomiasis vaccine is a key objective for disease eradication.
Previous efforts have faced challenges, requiring coordinated international collaboration.

Purpose of the Study:

To review the current status of schistosomiasis vaccine development.
To consolidate international research efforts and progress.
To formulate recommendations for future vaccine research and development.

Main Methods:

Summary of deliberations from international meetings held in Cairo, Egypt (May 21-25, 1997).
Review of existing scientific data and progress in schistosomiasis vaccine research.
Expert consensus-building on critical issues and future strategies.

Main Results:

Identification of key challenges and opportunities in schistosomiasis vaccine development.
Consensus on the need for continued and intensified international collaboration.
Outlined strategic recommendations for advancing vaccine candidates through the development pipeline.

Conclusions:

Schistosomiasis vaccine development requires sustained global commitment and resource allocation.
Strategic planning and collaborative research are crucial for overcoming existing hurdles.
The reviewed efforts provide a roadmap for achieving a safe and effective schistosomiasis vaccine.